Portfolio

Gordian Surgical

Safe, simple, and secure, advancing surgical port access and wound closure

Technology Development

Business Development

Revenue

Exited

Founded

2012

CEO
Roi Hamtsani
UN SDGs
3
Contact Us
email email
Follow Us
linkedin
Investors
The Trendlines Group, B. Braun, private investment funds (China and Canada), private investors, including key opinion leaders (surgeons)

About

Gordian Surgical is revolutionizing laparoscopic surgery with cutting-edge technology designed to enhance efficiency and improve patient outcomes. Our flagship product, the TroClose™ integrated trocar and closure device, simplifies port access and wound closure, offering unparalleled safety and ease of use. TroClose™ ensures a seamless experience, initiating port site closure at the start of the procedure during trocar insertion. Our needleless device demonstrates a 75% reduction in tissue tension compared to manual suturing and traditional closure devices.

Market Need

Port site hernia rates in laparoscopic surgeries have been reported in the literature to be as high as 7%, often due to varying methods of closure that can compromise on both cost and time. Our revolutionary 2-in-1 integrated trocar and wound closure device, the TroClose™ system, has demonstrated a 0% port site hernia rate, providing a reliable, efficient, and cost-effective solution for surgeons worldwide. Backed by rigorous research and a commitment to excellence, Gordian Surgical is redefining standards in surgical care.

Skip to content